Profil
Cheryl A. Madsen is currently the Senior Vice President-Regulatory Affairs at Viracta Therapeutics, Inc. She previously worked as the Senior Director at Medivation, Inc., Vice President-Regulatory Affairs at Peloton Therapeutics, Inc., and Vice President-Regulatory Affairs at Calithera Biosciences, Inc. She obtained her undergraduate degree from the University of California, Santa Cruz.
Aktive Positionen von Cheryl A. Madsen
| Unternehmen | Position | Beginn |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | General Counsel | - |
Ehemalige bekannte Positionen von Cheryl A. Madsen
| Unternehmen | Position | Ende |
|---|---|---|
| PELOTON THERAPEUTICS, INC. | General Counsel | - |
Medivation, Inc. /Old/
Medivation, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Corporate Officer/Principal | - |
| CALITHERA BIOSCIENCES, INC. | General Counsel | - |
Ausbildung von Cheryl A. Madsen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Peloton Therapeutics, Inc.
Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Medivation, Inc. /Old/
Medivation, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
University of California, Santa Cruz
University of California, Santa Cruz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calithera Biosciences, Inc.
Calithera Biosciences, Inc. BiotechnologyHealth Technology Develops novel therapeutics to control cancer and other diseases | Health Technology |
Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
















